US00287Y1091
Impact Score
AbbVie is a biopharmaceutical company that researches, develops, and markets both biopharmaceuticals and small molecule drugs. It focuses on therapeutic areas such as immunology, oncology, and virology.
Impact Score
Metric | Value | Unit | Year | PDF Name | PDF Page | |
---|---|---|---|---|---|---|
CEO-to-Employee Pay Ratio | ||||||
Richard A. Gonzalez | 2023 | 2023 Annual Report on Form 10-K and 2024 Proxy Statement ADA.pdf | 4 | |||
169 | ratio | 2023 | 2023 Annual Report on Form 10-K and 2024 Proxy Statement ADA.pdf | 193 | ||
Employee turnover rate | ||||||
9 | % | 2023 | abbvie-esg-action-report.pdf | 59 | ||
Glass Ceiling | ||||||
54 | % | 2023 | abbvie-esg-action-report.pdf | 62 | ||
56 | % | 2023 | abbvie-esg-action-report.pdf | 62 | ||
Greenhouse Gas Emissions | ||||||
328 259 | Metric Tons CO2e | 2023 | abbvie-esg-action-report.pdf | 20 | ||
53 000 | absolute | 2023 | abbvie-esg-action-report.pdf | 62 | ||
237 714 | Metric Tons CO2e | 2023 | abbvie-esg-action-report.pdf | 20 | ||
Harassment and Discrimination at the Workplace | ||||||
Yes | 2023 | our-commitment-to-human-rights.pdf | 2 | |||
Yes | 2023 | our-commitment-to-human-rights.pdf | 2 | |||
Yes | 2023 | our-commitment-to-human-rights.pdf | 2 | |||
Yes | 2023 | our-commitment-to-human-rights.pdf | 2 | |||
Renewable Energy | ||||||
2 317 472 | MWh | 2023 | abbvie-esg-action-report.pdf | 22 | ||
298 765 | MWh | 2023 | abbvie-esg-action-report.pdf | 22 | ||
Union Formation and Collective Bargaining Power | ||||||
25 | % | 2023 | abbvie-esg-action-report.pdf | 79 | ||
Recycling and Recovery of Waste | ||||||
40 | % | 2023 | abbvie-esg-action-report.pdf | 26 | ||
Women on the Board | ||||||
13 | absolute | 2023 | abbvie-esg-action-report.pdf | 75 | ||
11 | OFFICERS | 2023 | 2023 Annual Report on Form 10-K and 2024 Proxy Statement ADA.pdf | 42 | ||
1 | OFFICERS | 2023 | 2023 Annual Report on Form 10-K and 2024 Proxy Statement ADA.pdf | 42 | ||
5 | Women | 2023 | abbvie-esg-action-report.pdf | 62 | ||
Women in Management | ||||||
54 | % | 2023 | abbvie-esg-action-report.pdf | 62 |